No Association between Systemic Sclerosis and C77G Polymorphism in the Human PTPRC (CD45) Gene

Journal of Rheumatology

Volumn 35, Issue 9, 2008, Pages 1817-1819

  Kirsten, Holger ^a   Blume, Mechthild ^a   Emmrich, Frank ^a   Hunzelmann, Nico ^b   Mierau, Rudolf ^c   Rzepka, Rita ^d   Vaith, Peter ^d   Witte, Torsten ^e   Melchers, Inga ^d   Ahnert, Peter ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Rheumaklinik Aachen   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Autoimmunity; CD45 antigens; Leukocyte common antigen; Scleroderma; Single nucleotide polymorphism; Systemic sclerosis

Indexed keywords

AUTOANTIBODY; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE C; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION; PRIORITY JOURNAL; RISK; RISK FACTOR; SEX; SYSTEMIC SCLEROSIS;

ANTIGENS, CD45; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERMANY; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SCLERODERMA, SYSTEMIC;

EID: 54049111478     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Tchilian EZ, Beverley PC. Altered CD45 expression and disease. Trends Immunol 2006;27:146-53.
2. Dawes R, Petrova S, Liu Z, Wraith D, Beverley PC, Tchilian EZ. Combinations of CD45 isoforms are crucial for immune function and disease. J Immunol 2006;176:3417-25.
3. Lynch KW, Weiss A. A CD45 polymorphism associated with multiple sclerosis disrupts an exonic splicing silencer. J Biol Chem 2001;276:24341-7.
4. Dawes R, Hennig B, Irving W, et al. Altered CD45 expression in C77G carriers influences immune function and outcome of hepatitis C infection. J Med Genet 2006;43:678-84.
5. Do HT, Baars W, Borns K, Windhagen A, Schwinzer R. The 77C-G mutation in the human CD45 (PTPRC) gene leads to increased intensity of TCR signaling in T cell lines from healthy individuals and patients with multiple sclerosis. J Immunol 2006;176:931-8.
6. Schwinzer R, Witte T, Hundrieser J, et al. Enhanced frequency of a PTPRC (CD45) exon A mutation (77C-G) in systemic sclerosis. Genes Immun 2003;4:168-9.
7. LeRoy EC, Black C, Fleischmajer R Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
8. Dick T, Mierau R, Bartz-Bazzanella P, et al. Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis. Ann Rheum Dis 2002;61:121-7.
9. Kirsten H, Teupser D, Weissfuss J, Wolfram G, Emmrich F, Ahnert P. Robustness of single-base extension against mismatches at the site of primer attachment in a clinical assay. J Mol Med 2007;85:361-9.
10. Gordon D, Finch SJ, Nothnagel M, Ott J. Power and sample size calculations for case-control genetic association tests when errors are present: application to single nucleotide polymorphisms. Hum Hered 2002;54:22-33.
11. Garnier S, Dieude P, Michou L, et al. IRF5 rs2004640-T allele, the new genetic factor for systemic lupus erythematosus, is not associated with rheumatoid arthritis. Ann Rheum Dis 2007;66:828-31.
12. Ho KT, Reveille JD. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 2003;5:80-93.
13. Martin DO, Austin H. An exact method for meta-analysis of case-control and follow-up studies. Epidemiology 2000;11:255-60.
14. Miterski B, Drynda S, Boschow G, et al. Complex genetic predisposition in adult and juvenile rheumatoid arthritis. BMC Genet 2004;5:2.
15. Nadeau JH. Modifier genes and protective alleles in humans and mice. Curr Opin Genet Dev 2003;13:290-5.